Eric L. Michelson

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Salim Yusuf, Marc A. Pfeffer, Karl Swedberg et al. · The Lancet · 2003 · 3K citations

Medicine, Cardiology, Internal Medicine +12

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

John J.V. McMurray, Jan Östergren, Karl Swedberg et al. · The Lancet · 2003 · 2.6K citations

Medicine, Cardiology, Pharmacology +15

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger et al. · The Lancet · 2003 · 1.9K citations

Pharmacy, Cardiology, Pharmacotherapy +11

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

Christopher B. Granger, John J.V. McMurray, Salim Yusuf et al. · The Lancet · 2003 · 1.7K citations

Medicine, Cardiology, Pharmacology +15

CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL

John J.V. McMurray, Jan Östergren, Karl Swedberg et al. · The Lancet · 2003 · 1K citations

Medicine, Cardiology, Pharmacology +13